[{"_1":2,"_1036":-5,"_1037":-5},"loaderData",{"_3":4,"_11":12},"root",{"_5":6,"_7":8,"_9":10},"theme",0,"baseURL","https://pocketcasts.com","locale","en","routes/_app.podcast.$podcastSlug.$podcastUuid.$episodeSlug.$episodeUuid",{"_13":14,"_15":16,"_17":18},"podcastUuid","7a567eb0-1c1b-0135-52f8-452518e2d253","episodeUuid","388fa9f4-b276-4a85-8c4c-8910828ef31e","dehydratedState",{"_19":20,"_21":22},"mutations",[],"queries",[23,1030],{"_24":25,"_26":27,"_1024":1025,"_1028":1029},"dehydratedAt",1771938673433,"state",{"_28":29,"_1009":1010,"_1011":1012,"_1013":-5,"_1014":6,"_1015":6,"_1016":6,"_1017":-5,"_1018":-5,"_1019":35,"_1020":1021,"_1022":1023},"data",{"_30":31,"_32":33,"_34":35,"_36":6,"_37":38,"_39":35,"_40":41},"episode_frequency","Monthly","estimated_next_episode_at","2026-01-14T15:00:00Z","has_seasons",false,"season_count","episode_count",118,"has_more_episodes","podcast",{"_42":43,"_44":45,"_46":47,"_48":49,"_50":51,"_52":53,"_54":55,"_56":57,"_58":59,"_60":14,"_61":62,"_63":64,"_65":35,"_66":57,"_67":68},"url","https://jamanetwork.com/journals/jamacardiology/pages/jama-cardiology-author-interviews","title","JAMA Cardiology Author Interviews","slug","jama-cardiology-author-interviews","author","JAMA Network","description","Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide.\nJAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.","description_html","Interviews with authors of articles from JAMA Cardiology. JAMA Cardiology publishes exceptional original research, state-of-the-art reviews, and informative opinions that advance the science and practice of cardiology, enhance cardiovascular health, and inform health care policy. JAMA Cardiology is the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide.
JAMA Cardiology focuses on all aspects of cardiovascular medicine, including epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy and outcomes, and global health.","category","Health & Fitness\n Medicine\nScience","audio",true,"show_type","episodic","uuid","fundings",[],"guid","","is_private","transcript_eligible","episodes",[69,84,92,100,108,115,123,131,139,147,155,163,171,179,187,195,203,211,219,227,235,243,251,259,267,275,283,291,299,307,315,323,330,337,345,353,361,369,377,385,393,400,408,416,424,432,440,447,455,463,471,479,487,495,503,511,518,526,534,542,550,558,566,574,582,590,598,605,613,621,629,637,645,653,661,669,677,685,693,701,709,717,725,733,741,749,757,765,773,781,789,797,805,813,821,829,837,845,853,860,868,876,884,891,899,906,914,922,930,938,946,954,962,970,978,986,994,1001],{"_60":70,"_44":71,"_46":72,"_42":73,"_74":75,"_76":77,"_78":79,"_80":81,"_82":83},"f9f42812-3ca3-43d9-ab15-d8cbbd96653a","Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement","mechanisms-underlying-alterations-in-cardiac-conduction-after-transcatheter-aortic-valve-replacement","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Mechanisms_Underlying_Alterations_in_Cardiac_Conduction.mp3?dest-id=421999","file_type","audio/mpeg","file_size",44889160,"duration",1121,"published","2025-12-10T16:00:00Z","type","full",{"_60":85,"_44":86,"_46":87,"_42":88,"_74":75,"_76":89,"_78":90,"_80":91,"_82":83},"71afb14c-ee02-4a03-8df8-e2fd936739a4","From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more","from-the-jama-network-from-esc-remote-monitoring-for-atrial-fibrillation-semaglutide-and-tirzepatide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and-more","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/CP2509-CAR-250901-jama-jas-ESC-v1.mp3?dest-id=421999",92255276,2307,"2025-09-16T16:00:00Z",{"_60":93,"_44":94,"_46":95,"_42":96,"_74":75,"_76":97,"_78":98,"_80":99,"_82":83},"dd681e89-5bdf-4659-b6c7-8418766d0a7e","Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure","transthyretin-cardiac-amyloidosis-in-older-black-and-hispanic-individuals-with-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Transthyretin_Cardiac_Amyloidosis_in_Older_Black_and_Hispanic_Individuals_With_Heart_Failure.mp3?dest-id=421999",42216476,1054,"2025-09-10T15:00:00Z",{"_60":101,"_44":102,"_46":103,"_42":104,"_74":75,"_76":105,"_78":106,"_80":107,"_82":83},"2b685ffb-6574-4e5a-a18d-e5aa4336b693","Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF","clinical-outcomes-with-personalized-accelerated-physiologic-pacing-in-hfpef","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Clinical_Outcomes_With_Personalized_Accelerated_Physiologic_Pacing_in_HFpEF.mp3?dest-id=421999",50101832,1252,"2025-08-27T15:00:00Z",{"_60":16,"_44":109,"_46":110,"_42":111,"_74":75,"_76":112,"_78":113,"_80":114,"_82":83},"Preserving and Promoting Clinical Trial Representativeness","preserving-and-promoting-clinical-trial-representativeness","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Preserving_and_Promoting_Clinical_Trial_Representativeness.mp3?dest-id=421999",38563445,963,"2025-07-30T15:00:00Z",{"_60":116,"_44":117,"_46":118,"_42":119,"_74":75,"_76":120,"_78":121,"_80":122,"_82":83},"62e73c67-562e-417d-837f-f49a15be7715","CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy","ct-angiography-healthy-lifestyle-behaviors-and-preventive-therapy","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/CT_Angiography_Healthy_Lifestyle_Behaviors_and_Preventive_Therapy.mp3?dest-id=421999",45225164,1131,"2025-06-18T15:00:00Z",{"_60":124,"_44":125,"_46":126,"_42":127,"_74":75,"_76":128,"_78":129,"_80":130,"_82":83},"d66032be-0b2e-4d3f-9ad3-8c94e17e6ae3","Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation","cardiomyopathy-associated-gene-variants-in-atrial-fibrillation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Cardiomyopathy-Associated_Gene_Variants_in_Atrial_Fibrillation.mp3?dest-id=421999",37160315,928,"2025-04-30T15:00:00Z",{"_60":132,"_44":133,"_46":134,"_42":135,"_74":75,"_76":136,"_78":137,"_80":138,"_82":83},"c192665c-746d-4dbc-95ab-6511c167d8ab","Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation","encouraging-pharmacist-referrals-for-evidence-based-statin-initiation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Encouraging_Pharmacist_Referrals_for_Evidence-Based_Statin_Initiation.mp3?dest-id=421999",46845555,1170,"2025-03-26T15:00:00Z",{"_60":140,"_44":141,"_46":142,"_42":143,"_74":75,"_76":144,"_78":145,"_80":146,"_82":83},"a24c609f-98a5-48e1-8b82-b10bdfab8fdf","Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South Africa","sodium-reduction-legislation-and-urinary-sodium-and-blood-pressure-in-south-africa","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Sodium_Reduction_Legislation_and_Urinary_Sodium_and_Blood_Pressure_in_South_Africa.mp3?dest-id=421999",44316094,1107,"2025-02-05T16:00:00Z",{"_60":148,"_44":149,"_46":150,"_42":151,"_74":75,"_76":152,"_78":153,"_80":154,"_82":83},"c4a36fb9-8360-43b9-9717-74260de6e351","Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation","prevalence-of-hfpef-in-isolated-severe-secondary-tricuspid-regurgitation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Prevalence_of_HFpEF_in_Isolated_Severe_Secondary_Tricuspid_Regurgitation.mp3?dest-id=421999",26118979,652,"2024-11-06T16:00:00Z",{"_60":156,"_44":157,"_46":158,"_42":159,"_74":75,"_76":160,"_78":161,"_80":162,"_82":83},"73955b0a-528d-425e-a7f7-c41171d30462","Heart Failure Medical Therapy Score and Clinical Outcomes","heart-failure-medical-therapy-score-and-clinical-outcomes","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Heart_Failure_Medical_Therapy_Score_and_Clinical_Outcomes.mp3?dest-id=421999",36077711,901,"2024-09-25T15:00:00Z",{"_60":164,"_44":165,"_46":166,"_42":167,"_74":75,"_76":168,"_78":169,"_80":170,"_82":83},"9e130140-c4cb-47b8-be2f-d5001a8e13e8","Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants","prevalence-cardiac-phenotype-and-outcomes-of-transthyretin-variants","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Prevalence_Cardiac_Phenotype_and_Outcomes_of_Transthyretin_Variants.mp3?dest-id=421999",48486874,1211,"2024-08-28T15:00:00Z",{"_60":172,"_44":173,"_46":174,"_42":175,"_74":75,"_76":176,"_78":177,"_80":178,"_82":83},"ce197c09-73e1-4593-8d4b-ac6b947728f0","Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure","leadless-ultrasound-based-cardiac-resynchronization-system-in-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Leadless_Ultrasound-Based_Cardiac_Resynchronization_System_in_Heart_Failure.mp3?dest-id=421999",48110798,1202,"2024-07-31T15:00:00Z",{"_60":180,"_44":181,"_46":182,"_42":183,"_74":75,"_76":184,"_78":185,"_80":186,"_82":83},"c20ee634-60c9-4320-8609-faa129c51f27","Postpartum Ambulatory Blood Pressure and New-Onset Hypertensive Disorders of Pregnancy","postpartum-ambulatory-blood-pressure-and-new-onset-hypertensive-disorders-of-pregnancy","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Postpartum_Ambulatory_Blood_Pressure_and_New-Onset_Hypertensive_Disorders_of_Pregnancy.mp3?dest-id=421999",42663188,1067,"2024-06-12T15:00:00Z",{"_60":188,"_44":189,"_46":190,"_42":191,"_74":75,"_76":192,"_78":193,"_80":194,"_82":83},"d9c96c68-8591-41f3-a0dc-24c40c1d821b","Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement","osteosarcopenia-and-mortality-in-older-adults-undergoing-transcatheter-aortic-valve-replacement","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Osteosarcopenia_and_Mortality_in_Older_Adults_Undergoing_Transcatheter_Aortic_Valve_Replacement.mp3?dest-id=421999",55118266,1377,"2024-05-15T15:00:00Z",{"_60":196,"_44":197,"_46":198,"_42":199,"_74":75,"_76":200,"_78":201,"_80":202,"_82":83},"58a6d5ec-9566-4e08-8c12-a6eae98d8df8","Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction","atrial-shunt-device-effects-on-cardiac-structure-and-function-in-heart-failure-with-preserved-ejection-fraction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Atrial20Shunt20Device20Effects20on20Cardiac20Structure20and20Function20in20Heart20Failure20With20Preserved20Ejection20Fraction.mp3?dest-id=421999",44440325,1110,"2024-04-17T15:00:00Z",{"_60":204,"_44":205,"_46":206,"_42":207,"_74":75,"_76":208,"_78":209,"_80":210,"_82":83},"9b0fad14-6c08-4173-8d2d-6debf7122530","A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I","a-revised-definition-of-left-bundle-branch-block-using-time-to-notch-in-lead-i","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/A_Revised_Definition_of_Left_Bundle_Branch_Block_Using_Time_to_Notch_in_Lead_I.mp3?dest-id=421999",41521703,1039,"2024-03-27T15:00:00Z",{"_60":212,"_44":213,"_46":214,"_42":215,"_74":75,"_76":216,"_78":217,"_80":218,"_82":83},"c136a5f6-19fd-4603-925b-a5db668dd1c6","Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV","effects-of-pitavastatin-on-coronary-artery-disease-and-inflammatory-biomarkers-in-hiv","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Effects_of_Pitavastatin_on_Coronary_Artery_Disease_and_Inflammatory_Biomarkers_in_HIV.mp3?dest-id=421999",51083048,1278,"2024-02-21T16:00:00Z",{"_60":220,"_44":221,"_46":222,"_42":223,"_74":75,"_76":224,"_78":225,"_80":226,"_82":83},"d549a532-e495-4077-81dd-9aab5c27a589","Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy","effect-of-tafamidis-on-cardiac-function-in-patients-with-transthyretin-amyloid-cardiomyopathy","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Effect_of_Tafamidis_on_Cardiac_Function_in_Patients_With_Transthyretin_Amyloid_Cardiomyopathy.mp3?dest-id=421999",52353809,1308,"2023-11-15T16:00:00Z",{"_60":228,"_44":229,"_46":230,"_42":231,"_74":75,"_76":232,"_78":233,"_80":234,"_82":83},"44017572-bca3-4ecb-b246-fec1cc32b461","Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction","viability-and-outcomes-with-revascularization-or-medical-therapy-in-ischemic-ventricular-dysfunction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Viability_and_Outcomes_With_Revascularization_or_Medical_Therapy_in_Ischemic_Ventricular_Dysfunction.mp3?dest-id=421999",50353803,1258,"2023-10-25T15:00:00Z",{"_60":236,"_44":237,"_46":238,"_42":239,"_74":75,"_76":240,"_78":241,"_80":242,"_82":83},"5da54d5a-8822-4341-8e81-9c1576011ee6","Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020","prevalence-and-overlap-of-cardiac-renal-and-metabolic-conditions-in-us-adults-1999-2020","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Prevalence_and_Overlap_of_Cardiac_Renal_and_Metabolic_Conditions_in_US_Adults_1999-2020.mp3?dest-id=421999",44183402,1104,"2023-09-27T15:00:00Z",{"_60":244,"_44":245,"_46":246,"_42":247,"_74":75,"_76":248,"_78":249,"_80":250,"_82":83},"80701108-a8da-4a26-81a0-596a43f6fd05","Assisted Reproductive Technologies and Maternal Cardiovascular Disease","assisted-reproductive-technologies-and-maternal-cardiovascular-disease","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Assisted_Reproductive_Technologies_and_Maternal_Cardiovascular_Disease.mp3?dest-id=421999",28864969,721,"2023-08-09T15:00:00Z",{"_60":252,"_44":253,"_46":254,"_42":255,"_74":75,"_76":256,"_78":257,"_80":258,"_82":83},"1ec53e56-e25e-4eba-be6c-72193bbbb7e1","Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping","tracking-treatment-response-in-cardiac-light-chain-amyloidosis-with-native-t1-mapping","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Tracking_Treatment_Response_in_Cardiac_Light-Chain_Amyloidosis_With_Native_T1_Mapping.mp3?dest-id=421999",49564331,1238,"2023-07-19T15:00:00Z",{"_60":260,"_44":261,"_46":262,"_42":263,"_74":75,"_76":264,"_78":265,"_80":266,"_82":83},"8283abf1-517b-40a6-b863-204303f74a39","Percutaneous Microaxial Left Ventricular Assist Device for Patients With Cardiogenic Shock","percutaneous-microaxial-left-ventricular-assist-device-for-patients-with-cardiogenic-shock","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Percutaneous_Microaxial_Left_Ventricular_Assist_Device_for_Patients_With_Cardiogenic_Shock.mp3?dest-id=421999",48405791,1209,"2023-06-21T15:00:00Z",{"_60":268,"_44":269,"_46":270,"_42":271,"_74":75,"_76":272,"_78":273,"_80":274,"_82":83},"6012c660-c9eb-441a-b6a9-6d9942f2fc35","Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy","vigorous-exercise-in-patients-with-hypertrophic-cardiomyopathy","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Vigorous_Exercise_in_Patients_With_Hypertrophic_Cardiomyopathy.mp3?dest-id=421999",50694783,1266,"2023-05-17T15:00:00Z",{"_60":276,"_44":277,"_46":278,"_42":279,"_74":75,"_76":280,"_78":281,"_80":282,"_82":83},"4a2a6afd-ded7-4050-bb01-70ab4289dc07","Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials","ultrasound-renal-denervation-in-the-sham-controlled-radiance-ii-radiance-htn-solo-and-radiance-htn-trio-trials","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Ultrasound_Renal_Denervation_in_the_Sham-Controlled_RADIANCE_II_RADIANCE-HTN_SOLO_and_RADIANCE-HTN_TRIO_Trials.mp3?dest-id=421999",15899074,991,"2023-04-26T15:00:00Z",{"_60":284,"_44":285,"_46":286,"_42":287,"_74":75,"_76":288,"_78":289,"_80":290,"_82":83},"086e9d2e-a2c7-4057-b56d-696710a45dd4","Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma","association-of-preexisting-heart-failure-with-outcomes-in-older-patients-with-diffuse-large-b-cell-lymphoma","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Preexisting_Heart_Failure_With_Outcomes_in_Older_Patients_With_Diffuse_Large_B-Cell_Lymphoma.mp3?dest-id=421999",49912142,1247,"2023-03-29T15:00:00Z",{"_60":292,"_44":293,"_46":294,"_42":295,"_74":75,"_76":296,"_78":297,"_80":298,"_82":83},"44f9ff84-c960-4597-8f8e-8dd2df681835","Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care","prevalence-and-prognostic-significance-of-bradyarrhythmias-in-patients-screened-for-atrial-fibrillation-vs-usual-care","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Prevalence_and_Prognostic_Significance_of_Bradyarrhythmias_in_Patients_Screened_for_Atrial_Fibrillation_vs_Usual_Care-4.mp3?dest-id=421999",65321770,1632,"2023-02-15T16:00:00Z",{"_60":300,"_44":301,"_46":302,"_42":303,"_74":75,"_76":304,"_78":305,"_80":306,"_82":83},"03ba2249-f2dd-4d85-b67f-c9b50b874c8f","Structural Valve Deterioration After Self-Expanding Transcatheter or Surgical Aortic Valve Implantation","structural-valve-deterioration-after-self-expanding-transcatheter-or-surgical-aortic-valve-implantation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Structural_Valve_Deterioration_After_Self-Expanding_Transcatheter_or_Surgical_Aortic_Valve_Implantation.mp3?dest-id=421999",41409344,1036,"2022-12-14T16:00:00Z",{"_60":308,"_44":309,"_46":310,"_42":311,"_74":75,"_76":312,"_78":313,"_80":314,"_82":83},"804b7de6-bac1-4957-8aec-f8fa44066514","Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing","effect-of-nudges-to-clinicians-patients-or-both-to-increase-statin-prescribing","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Effect_of_Nudges_to_Clinicians_Patients_or_Both_to_Increase_Statin_Prescribing.mp3?dest-id=421999",40541152,1013,"2022-11-30T16:00:00Z",{"_60":316,"_44":317,"_46":318,"_42":319,"_74":75,"_76":320,"_78":321,"_80":322,"_82":83},"7e4a56d3-d8b2-4b91-b627-052c3dcfd14f","Treatment of Hypertension in 2022","treatment-of-hypertension-in-2022","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Treatment_of_Hypertension_in_2022.mp3?dest-id=421999",26381876,1648,"2022-11-08T16:00:00Z",{"_60":324,"_44":325,"_46":326,"_42":327,"_74":75,"_76":328,"_78":209,"_80":329,"_82":83},"eace01c6-6d90-46b7-8a36-9dc93b1c5658","Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control","longer-term-all-cause-and-cardiovascular-mortality-with-intensive-blood-pressure-control","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Longer-Term_All-Cause_and_Cardiovascular_Mortality_With_Intensive_Blood_Pressure_Control.mp3?dest-id=421999",16677753,"2022-10-12T15:00:00Z",{"_60":331,"_44":332,"_46":333,"_42":334,"_74":75,"_76":335,"_78":177,"_80":336,"_82":83},"0342e50b-e693-4a3a-99f7-f436792d921d","Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features","burden-of-rare-genetic-variants-in-spontaneous-coronary-artery-dissection-with-high-risk-features","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Burden_of_Rare_Genetic_Variants_in_Spontaneous_Coronary_Artery_Dissection_With_High-risk_Features.mp3?dest-id=421999",19223411,"2022-09-14T15:00:00Z",{"_60":338,"_44":339,"_46":340,"_42":341,"_74":75,"_76":342,"_78":343,"_80":344,"_82":83},"f0b20ac9-9857-4b9f-9516-f84b8c2acee8","Alerting Clinicians to 1-Year Mortality Risk in Patients Hospitalized With Heart Failure","alerting-clinicians-to-1-year-mortality-risk-in-patients-hospitalized-with-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Alerting_Clinicians_to_1-Year_Mortality_Risk_in_Patients_Hospitalized_With_Heart_Failure.mp3?dest-id=421999",41313753,1031,"2022-08-10T15:00:00Z",{"_60":346,"_44":347,"_46":348,"_42":349,"_74":75,"_76":350,"_78":351,"_80":352,"_82":83},"82dc4cc2-389e-44dc-9c1d-98c233d42e93","Association of LV Remodeling Assessment by CMR With Outcomes in Patients With Chronic Aortic Regurgitation","association-of-lv-remodeling-assessment-by-cmr-with-outcomes-in-patients-with-chronic-aortic-regurgitation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_LV_Remodeling_Assessment_by_CMR_With_Outcomes_in_Patients_With_Chronic_Aortic_Regurgitation.mp3?dest-id=421999",19226587,1198,"2022-07-20T15:00:00Z",{"_60":354,"_44":355,"_46":356,"_42":357,"_74":75,"_76":358,"_78":359,"_80":360,"_82":83},"bf659c54-1fb4-4728-8e9f-89810e883a9a","Machine Learning–Based Models Incorporating SDOH vs Traditional Models for Predicting In-Hospital Mortality For Heart Failure","machine-learningbased-models-incorporating-sdoh-vs-traditional-models-for-predicting-in-hospital-mortality-for-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Machine_LearningBased_Models_Incorporating_SDOH_vs_Traditional_Models_for_Predicting_In-Hospital_Mortality_For_Heart_Failure.mp3?dest-id=421999",13328704,830,"2022-07-06T15:00:00Z",{"_60":362,"_44":363,"_46":364,"_42":365,"_74":75,"_76":366,"_78":367,"_80":368,"_82":83},"ecf70d0d-3041-4419-90e1-a52b448f55cf","A Conversation With Dr Kirsten Bibbins-Domingo, JAMA's New Editor in Chief","a-conversation-with-dr-kirsten-bibbins-domingo-jamas-new-editor-in-chief","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/A_Conversation_With_Dr_Kirsten_Bibbins-Domingo_JAMAs_New_Editor_in_Chief.mp3?dest-id=421999",21329314,1327,"2022-07-05T15:00:00Z",{"_60":370,"_44":371,"_46":372,"_42":373,"_74":75,"_76":374,"_78":375,"_80":376,"_82":83},"b6d156db-f4d0-4a4e-88eb-a110dcbdc6a9","Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes","association-of-pathogenic-dna-variants-predisposing-to-cardiomyopathy-with-cardiovascular-disease-outcomes","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Pathogenic_DNA_Variants_Predisposing_to_Cardiomyopathy_With_Cardiovascular_Disease_Outcomes.mp3?dest-id=421999",59479892,1481,"2022-05-11T15:00:00Z",{"_60":378,"_44":379,"_46":380,"_42":381,"_74":75,"_76":382,"_78":383,"_80":384,"_82":83},"11f92610-e65e-4070-b513-2205c4959afc","Sex and Race Differences in NT-proBNP Concentration and Absolute Risk of Heart Failure in the Community","sex-and-race-differences-in-nt-probnp-concentration-and-absolute-risk-of-heart-failure-in-the-community","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Sex_and_Race_Differences_in_NT-proBNP_Concentration_and_Absolute_Risk_of_Heart_Failure_in_the_Community.mp3?dest-id=421999",28720108,714,"2022-04-27T15:00:00Z",{"_60":386,"_44":387,"_46":388,"_42":389,"_74":75,"_76":390,"_78":391,"_80":392,"_82":83},"3eb94633-e9bc-4863-81d9-52719780fbda","Performance of Guideline-Recommended Strategies for Hospitalized Patients With STEMI in China","performance-of-guideline-recommended-strategies-for-hospitalized-patients-with-stemi-in-china","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Performance_of_Guideline-Recommended_Strategies_for_Hospitalized_Patients_With_STEMI_in_China.mp3?dest-id=421999",13784105,852,"2022-03-16T15:00:00Z",{"_60":394,"_44":395,"_46":396,"_42":397,"_74":75,"_76":398,"_78":273,"_80":399,"_82":83},"d31a8562-5d56-42ff-ae4c-dc577d505159","N-Terminal Pro-Brain Natriuretic Peptide Measurements in Patients With Aortic Stenosis","n-terminal-pro-brain-natriuretic-peptide-measurements-in-patients-with-aortic-stenosis","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/N-Terminal_Pro-Brain_Natriuretic_Peptide_Measurements_in_Patients_With_Aortic_Stenosis.mp3?dest-id=421999",20291227,"2022-02-16T16:00:00Z",{"_60":401,"_44":402,"_46":403,"_42":404,"_74":75,"_76":405,"_78":406,"_80":407,"_82":83},"af6d9f0b-9432-421e-9132-5a3c4ff29c83","Association of Plaque Location and Vessel Geometry With Future ACS–Causing Culprit Lesions","association-of-plaque-location-and-vessel-geometry-with-future-acscausing-culprit-lesions","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Plaque_Location_and_Vessel_Geometry_With_Future_ACSCausing_Culprit_Lesions.mp3?dest-id=421999",19986807,1248,"2022-01-26T16:00:00Z",{"_60":409,"_44":410,"_46":411,"_42":412,"_74":75,"_76":413,"_78":414,"_80":415,"_82":83},"0b8a56f2-0739-4d0b-8107-b2f504e1ef05","Association of Health Care Processes With Racial or Ethnic Disparities in Blood Pressure Control","association-of-health-care-processes-with-racial-or-ethnic-disparities-in-blood-pressure-control","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Health_Care_Processes_With_Racial_or_Ethnic_Disparities_in_Blood_Pressure_Control.mp3?dest-id=421999",22112947,1381,"2021-12-08T16:00:00Z",{"_60":417,"_44":418,"_46":419,"_42":420,"_74":75,"_76":421,"_78":422,"_80":423,"_82":83},"ff2ebe19-1385-4f45-9d02-1ba6eb80d597","Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction","treatment-with-sacubitrilvalsartan-in-patients-with-advanced-heart-failure-and-reduced-ejection-fraction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Treatment_With_Sacubitril_Valsartan_in_Patients_With_Advanced_Heart_Failure_and_Reduced_Ejection_Fraction.mp3?dest-id=421999",16798537,1042,"2021-11-03T15:00:00Z",{"_60":425,"_44":426,"_46":427,"_42":428,"_74":75,"_76":429,"_78":430,"_80":431,"_82":83},"914b0e4f-bd01-441d-a1fd-6afba13523c8","Long-term Clinical Outcomes of Skeletonized vs Pedicled Internal Thoracic Artery Harvesting in the ART Trial","long-term-clinical-outcomes-of-skeletonized-vs-pedicled-internal-thoracic-artery-harvesting-in-the-art-trial","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Long-term_Clinical_Outcomes_of_Skeletonized_vs_Pedicled_Internal_Thoracic_Artery_Harvesting_in_the_ART_Trial.mp3?dest-id=421999",66814242,1666,"2021-09-29T15:00:00Z",{"_60":433,"_44":434,"_46":435,"_42":436,"_74":75,"_76":437,"_78":438,"_80":439,"_82":83},"f18fc79e-cbb8-4f71-96cd-ddc676efa9d2","Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic Stenosis","association-of-myocardial-blood-flow-reserve-with-adverse-left-ventricular-remodeling-in-patients-with-aortic-stenosis","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association-of-Myocardial-Blood-Flow-Reserve-With-Adverse-Left-Ventricular-Remodeling-in-Patients-With-Aortic-Stenosis.mp3?dest-id=421999",40398929,1009,"2021-09-15T15:00:00Z",{"_60":441,"_44":442,"_46":443,"_42":444,"_74":75,"_76":445,"_78":289,"_80":446,"_82":83},"224c0df6-a3f1-4907-b000-a207866a756b","Transthyretin Amyloid Cardiomyopathy in Patients With Heart Failure With Preserved Ejection Fraction","transthyretin-amyloid-cardiomyopathy-in-patients-with-heart-failure-with-preserved-ejection-fraction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Transthyretin_Amyloid_Cardiomyopathy_in_Patients_With_Heart_Failure_With_Preserved_Ejection_Fraction.mp3?dest-id=421999",25001434,"2021-08-25T15:00:00Z",{"_60":448,"_44":449,"_46":450,"_42":451,"_74":75,"_76":452,"_78":453,"_80":454,"_82":83},"cabcf568-6636-4529-b51c-a5e1fdf4551f","Posttraumatic Stress Disorder and Cardiovascular Disease","posttraumatic-stress-disorder-and-cardiovascular-disease","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Posttraumatic_Stress_Disorder_and_Cardiovascular_Disease.mp3?dest-id=421999",19953601,1244,"2021-07-14T15:00:00Z",{"_60":456,"_44":457,"_46":458,"_42":459,"_74":75,"_76":460,"_78":461,"_80":462,"_82":83},"838e6e87-f9cf-491c-8423-bf45dae189cf","Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Heart Failure","prevalence-of-coronary-artery-disease-and-coronary-microvascular-dysfunction-in-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Prevalence_of_Coronary_Artery_Disease_and_Coronary_Microvascular_Dysfunction_in_Heart_Failure.mp3?dest-id=421999",20946383,1306,"2021-06-23T15:00:00Z",{"_60":464,"_44":465,"_46":466,"_42":467,"_74":75,"_76":468,"_78":469,"_80":470,"_82":83},"cb4193c0-1853-480a-b026-59a279b3717a","Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction","association-of-socioeconomic-disadvantage-with-long-term-mortality-after-myocardial-infarction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Socioeconomic_Disadvantage_With_Long-term_Mortality_After_Myocardial_Infarction.mp3?dest-id=421999",20901188,1043,"2021-05-19T15:00:00Z",{"_60":472,"_44":473,"_46":474,"_42":475,"_74":75,"_76":476,"_78":477,"_80":478,"_82":83},"ad44a5a3-eb5b-458e-ba94-a5b1fa794194","Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals","association-of-rare-genetic-variants-and-early-onset-atrial-fibrillation-in-ethnic-minority-individuals","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Rare_Genetic_Variants_and_Early-Onset_Atrial_Fibrillation_in_Ethnic_Minority_Individuals.mp3?dest-id=421999",23811500,1186,"2021-05-05T15:00:00Z",{"_60":480,"_44":481,"_46":482,"_42":483,"_74":75,"_76":484,"_78":485,"_80":486,"_82":83},"835f7979-a464-4600-92c0-c3b8ff2a23cb","New York Heart Association Class vs Patient-Reported Outcomes in Heart Failure","new-york-heart-association-class-vs-patient-reported-outcomes-in-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/New_York_Heart_Association_Class_vs_Patient-Reported_Outcomes_in_Heart_Failure.mp3?dest-id=421999",15032349,749,"2021-03-24T15:00:00Z",{"_60":488,"_44":489,"_46":490,"_42":491,"_74":75,"_76":492,"_78":493,"_80":494,"_82":83},"4f815dc4-df33-4006-a286-867a9523e0c3","Screening for Atrial Fibrillation in the Older Population","screening-for-atrial-fibrillation-in-the-older-population","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Screening_for_Atrial_Fibrillation_in_the_Older_Population.mp3?dest-id=421999",32000269,1598,"2021-02-24T16:00:00Z",{"_60":496,"_44":497,"_46":498,"_42":499,"_74":75,"_76":500,"_78":501,"_80":502,"_82":83},"77a920df-e1e8-4ab9-91e1-c38418aa231f","Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren","systematic-echocardiographic-screening-for-rheumatic-heart-disease-in-nepalese-schoolchildren","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Systematic_Echocardiographic_Screening_for_Rheumatic_Heart_Disease_in_Nepalese_Schoolchildren.mp3?dest-id=421999",20730719,1293,"2021-01-20T16:00:00Z",{"_60":504,"_44":505,"_46":506,"_42":507,"_74":75,"_76":508,"_78":509,"_80":510,"_82":83},"6babeac1-ae59-4860-b9c5-b03e31bb7742","Sex Differences in Multiple vs Single Arterial Grafting","sex-differences-in-multiple-vs-single-arterial-grafting","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Sex_Differences_in_Multiple_vs_Single_Arterial_Grafting.mp3?dest-id=421999",11099723,690,"2020-12-23T16:00:00Z",{"_60":512,"_44":513,"_46":514,"_42":515,"_74":75,"_76":516,"_78":265,"_80":517,"_82":83},"3726065a-61a2-4d39-87d8-540fcc190146","Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population","association-of-low-plasma-transthyretin-concentration-with-risk-of-heart-failure-in-the-general-population","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Low_Plasma_Transthyretin_Concentration_With_Risk_of_Heart_Failure_in_the_General_Population.mp3?dest-id=421999",19363628,"2020-11-25T16:00:00Z",{"_60":519,"_44":520,"_46":521,"_42":522,"_74":75,"_76":523,"_78":524,"_80":525,"_82":83},"2af6e753-c346-4d07-a2c5-b98e329850d4","COVID-19 and the Athletic Heart: Emerging Perspectives on Pathology, Risks, and Return-to-Play","covid-19-and-the-athletic-heart-emerging-perspectives-on-pathology-risks-and-return-to-play","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/COVID-19_and_the_Athletic_Heart__Emerging_Perspectives_on_Pathology_Risks_and_Return-to-Play.mp3?dest-id=421999",19833762,1230,"2020-10-26T15:00:00Z",{"_60":527,"_44":528,"_46":529,"_42":530,"_74":75,"_76":531,"_78":532,"_80":533,"_82":83},"f837a5ea-9466-4c37-a90e-541ef6ef9f37","Clinical Features and Outcomes of Pregnancy-Related Acute Aortic Dissection","clinical-features-and-outcomes-of-pregnancy-related-acute-aortic-dissection","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Clinical_Features_and_Outcomes_of_Pregnancy-Related_Acute_Aortic_Dissection.mp3?dest-id=421999",12620496,782,"2020-10-14T15:00:00Z",{"_60":535,"_44":536,"_46":537,"_42":538,"_74":75,"_76":539,"_78":540,"_80":541,"_82":83},"4217afc9-1186-4d2a-be56-7b9bcd01cef3","Adverse Pregnancy Outcomes and Risk of Atherosclerotic Cardiovascular Disease in Postmenopausal Women","adverse-pregnancy-outcomes-and-risk-of-atherosclerotic-cardiovascular-disease-in-postmenopausal-women","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Adverse_Pregnancy_Outcomes_and_Risk_of_Atherosclerotic_Cardiovascular_Disease_in_Postmenopausal_Women.mp3?dest-id=421999",12462445,765,"2020-09-16T15:00:00Z",{"_60":543,"_44":544,"_46":545,"_42":546,"_74":75,"_76":547,"_78":548,"_80":549,"_82":83},"621d63a1-68b6-448a-84a3-fe2a365cb0d4","Survival on the Heart Transplant Waiting List","survival-on-the-heart-transplant-waiting-list","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Survival_on_the_Heart_Transplant_Waiting_List.mp3?dest-id=421999",11375920,707,"2020-08-12T15:00:00Z",{"_60":551,"_44":552,"_46":553,"_42":554,"_74":75,"_76":555,"_78":556,"_80":557,"_82":83},"5d4d6bd2-53af-4685-8603-7de4040c2131","Low-Dose Triple Combination Therapy and Therapeutic Inertia and Prescribing Patterns in Hypertension","low-dose-triple-combination-therapy-and-therapeutic-inertia-and-prescribing-patterns-in-hypertension","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Low-Dose_Triple_Combination_Therapy_and_Therapeutic_Inertia_and_Prescribing_Patterns_in_Hypertension.mp3?dest-id=421999",12255804,760,"2020-07-22T15:00:00Z",{"_60":559,"_44":560,"_46":561,"_42":562,"_74":75,"_76":563,"_78":564,"_80":565,"_82":83},"b1fae628-f2cb-4e92-9644-e5bb238e8e0c","Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease Without Risk Factors","association-of-normal-systolic-blood-pressure-level-with-cardiovascular-disease-without-risk-factors","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Normal_Systolic_Blood_Pressure_Level_With_Cardiovascular_Disease_Without_Risk_Factors.mp3?dest-id=421999",10497704,650,"2020-06-10T15:00:00Z",{"_60":567,"_44":568,"_46":569,"_42":570,"_74":75,"_76":571,"_78":572,"_80":573,"_82":83},"e672c3d3-5404-482e-855e-14a18a3908c7","Association Between Malignant Mitral Valve Prolapse and Sudden Cardiac Death: A Review","association-between-malignant-mitral-valve-prolapse-and-sudden-cardiac-death-a-review","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_Between_Malignant_Mitral_Valve_Prolapse_and_Sudden_Cardiac_Death.mp3?dest-id=421999",25894740,1612,"2020-05-27T15:00:00Z",{"_60":575,"_44":576,"_46":577,"_42":578,"_74":75,"_76":579,"_78":580,"_80":581,"_82":83},"bf95dd58-5440-4a78-8fc6-aed4bd8e66fb","Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality","association-of-coronavirus-disease-2019-covid-19-with-myocardial-injury-and-mortality","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Coronavirus_Disease_2019_COVID-19_With_Myocardial_Injury_and_Mortality.mp3?dest-id=421999",23167680,1438,"2020-03-27T15:00:00Z",{"_60":583,"_44":584,"_46":585,"_42":586,"_74":75,"_76":587,"_78":588,"_80":589,"_82":83},"0d03d335-4f2e-4c18-8dc0-a970954c7c17","Rationale and Design of the ADAPTABLE Trial","rationale-and-design-of-the-adaptable-trial","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Rationale_and_Design_of_the_ADAPTABLE_Trial.mp3?dest-id=421999",19924407,1234,"2020-03-18T15:00:00Z",{"_60":591,"_44":592,"_46":593,"_42":594,"_74":75,"_76":595,"_78":596,"_80":597,"_82":83},"aabc413f-b1e4-4083-b260-5e16e8795159","Association of Ascending Aortic Dilatation and Long-term Endurance Exercise Among Older Athletes","association-of-ascending-aortic-dilatation-and-long-term-endurance-exercise-among-older-athletes","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Ascending_Aortic_Dilatation_and_Long-term_Endurance_Exercise_Among_Older_Athletes.mp3?dest-id=421999",15052990,936,"2020-02-26T16:00:00Z",{"_60":599,"_44":600,"_46":601,"_42":602,"_74":75,"_76":603,"_78":305,"_80":604,"_82":83},"450cd037-6b7c-4156-b76f-99198ccbe8d3","Sex Differences in Blood Pressure Trajectories Over the Life Course","sex-differences-in-blood-pressure-trajectories-over-the-life-course","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Sex_Differences_in_Blood_Pressure_Trajectories_Over_the_Life_Course.mp3?dest-id=421999",16700344,"2020-01-15T16:00:00Z",{"_60":606,"_44":607,"_46":608,"_42":609,"_74":75,"_76":610,"_78":611,"_80":612,"_82":83},"80fd1d51-1fe4-4c6c-8349-15177bc9f49a","Utility of 90-Day vs 30-Day Mortality Quality Metrics for Aortic Valve Replacement Outcomes","utility-of-90-day-vs-30-day-mortality-quality-metrics-for-aortic-valve-replacement-outcomes","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Utility_of_90-Day_vs_30-Day_Mortality_Quality_Metrics_for_Aortic_Valve_Replacement_Outcomes.mp3?dest-id=421999",18768932,1167,"2019-12-18T16:00:00Z",{"_60":614,"_44":615,"_46":616,"_42":617,"_74":75,"_76":618,"_78":619,"_80":620,"_82":83},"a213811b-24b5-44d5-bb63-d22d9bf4f930","Transcatheter Aortic Valve Replacement for Patients at Low Surgical Risk—Selective or Ubiquitous?","transcatheter-aortic-valve-replacement-for-patients-at-low-surgical-riskselective-or-ubiquitous","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Transcatheter_Aortic_Valve_Replacement_for_Patients_at_Low_Surgical_RiskSelective_or_Ubiquitous_.mp3?dest-id=421999",22376982,1390,"2019-11-13T16:00:00Z",{"_60":622,"_44":623,"_46":624,"_42":625,"_74":75,"_76":626,"_78":627,"_80":628,"_82":83},"80a57f28-428b-4e3a-a725-d8bdeb3b88b3","Longitudinal Associations Between Income Changes and Incident Cardiovascular Disease","longitudinal-associations-between-income-changes-and-incident-cardiovascular-disease","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Longitudinal_Associations_Between_Income_Changes_and_Incident_Cardiovascular_Disease.mp3?dest-id=421999",11509040,715,"2019-10-09T15:00:00Z",{"_60":630,"_44":631,"_46":632,"_42":633,"_74":75,"_76":634,"_78":635,"_80":636,"_82":83},"d4e9b40a-786e-454f-a587-a373283188f7","Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels","effect-of-1-or-2-doses-of-inclisiran-on-low-density-lipoprotein-cholesterol-levels","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Effect_of_1_or_2_Doses_of_Inclisiran_on_Low-Density_Lipoprotein_Cholesterol_Levels.mp3?dest-id=421999",23643697,1467,"2019-09-25T15:00:00Z",{"_60":638,"_44":639,"_46":640,"_42":641,"_74":75,"_76":642,"_78":643,"_80":644,"_82":83},"cf7b7611-88d3-447d-8a87-a020a11cec44","Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity","prognostic-value-of-global-longitudinal-strain-for-early-prediction-of-chemotherapy-induced-cardiotoxicity","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Prognostic_Value_of_Global_Longitudinal_Strain_for_Early_Prediction_of_Chemotherapy-Induced_Cardiotoxicity.mp3?dest-id=421999",24175381,1501,"2019-08-21T15:00:00Z",{"_60":646,"_44":647,"_46":648,"_42":649,"_74":75,"_76":650,"_78":651,"_80":652,"_82":83},"6dcc4010-a4ab-4984-b024-602b861ff21a","Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older","simvastatin-ezetimibe-compared-with-simvastatin-monotherapy-among-patients-75-years-or-older","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Simvastatin-Ezetimibe_Compared_With_Simvastatin_Monotherapy_Among_Patients_75_Years_or_Older.mp3?dest-id=421999",27930572,1739,"2019-07-17T15:00:00Z",{"_60":654,"_44":655,"_46":656,"_42":657,"_74":75,"_76":658,"_78":659,"_80":660,"_82":83},"8a3ce1b3-7da5-4332-8133-d664239fdb69","Coronary Anatomical Complexity and Clinical Outcomes After Percutaneous or Surgical Revascularization","coronary-anatomical-complexity-and-clinical-outcomes-after-percutaneous-or-surgical-revascularization","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Coronary_Anatomical_Complexity_and_Clinical_Outcomes_After_Percutaneous_or_Surgical_Revascularization.mp3?dest-id=421999",9667796,598,"2019-06-26T15:00:00Z",{"_60":662,"_44":663,"_46":664,"_42":665,"_74":75,"_76":666,"_78":667,"_80":668,"_82":83},"d6df2676-3f10-44fe-b241-8c3d8a5ffe28","Screening for Familial Hypercholesterolemia","screening-for-familial-hypercholesterolemia","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Screening_for_Familial_Hypercholesterolemia.mp3?dest-id=421999",22235309,1387,"2019-05-22T15:00:00Z",{"_60":670,"_44":671,"_46":672,"_42":673,"_74":75,"_76":674,"_78":675,"_80":676,"_82":83},"7ee3c84f-8c17-463b-bee5-f1ccce687870","Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm","rivaroxaban-and-thromboembolic-events-in-patients-with-heart-failure-coronary-disease-and-sinus-rhythm","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Rivaroxaban_and_Thromboembolic_Events_in_Patients_With_Heart_Failure_Coronary_Disease_and_Sinus_Rhythm.mp3?dest-id=421999",18265603,1135,"2019-04-24T15:00:00Z",{"_60":678,"_44":679,"_46":680,"_42":681,"_74":75,"_76":682,"_78":683,"_80":684,"_82":83},"8b8e567a-0a5f-49e4-8ebb-54d5df1e5d02","Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure","association-of-influenza-like-illness-activity-with-hospitalizations-for-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Influenza-like_Illness_Activity_With_Hospitalizations_for_Heart_Failure.mp3?dest-id=421999",17478429,1084,"2019-03-27T15:00:00Z",{"_60":686,"_44":687,"_46":688,"_42":689,"_74":75,"_76":690,"_78":691,"_80":692,"_82":83},"da13cbea-9323-487e-9395-058540ae2815","Association of Statin Adherence With Mortality in Patients With Atherosclerotic Cardiovascular Disease","association-of-statin-adherence-with-mortality-in-patients-with-atherosclerotic-cardiovascular-disease","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Statin_Adherence_With_Mortality_in_Patients_With_Atherosclerotic_Cardiovascular_Disease.mp3?dest-id=421999",19074564,1185,"2019-02-13T16:00:00Z",{"_60":694,"_44":695,"_46":696,"_42":697,"_74":75,"_76":698,"_78":699,"_80":700,"_82":83},"f6b97828-b206-40f0-93f4-2621fcbe54f9","Association of Mortality With High Levels of Physical Activity and Coronary Artery Calcification","association-of-mortality-with-high-levels-of-physical-activity-and-coronary-artery-calcification","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Mortality_With_High_Levels_of_Physical_Activity_and_Coronary_Artery_Calcification.mp3?dest-id=421999",23972244,1492,"2019-01-30T16:00:00Z",{"_60":702,"_44":703,"_46":704,"_42":705,"_74":75,"_76":706,"_78":707,"_80":708,"_82":83},"1b920e7e-440a-460e-8d94-85cd1bcfa085","Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure","association-of-mutations-contributing-to-clonal-hematopoiesis-with-prognosis-in-chronic-ischemic-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Mutations_Contributing_to_Clonal_Hematopoiesis_With_Prognosis_in_Chronic_Ischemic_Heart_Failure.mp3?dest-id=421999",19568271,1212,"2018-12-19T16:00:00Z",{"_60":710,"_44":711,"_46":712,"_42":713,"_74":75,"_76":714,"_78":715,"_80":716,"_82":83},"afdea4f6-5143-4370-bd65-73449f6df131","Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation","association-of-raceethnicity-with-oral-anticoagulant-use-in-patients-with-atrial-fibrillation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Race_Ethnicity_With_Oral_Anticoagulant_Use_in_Patients_With_Atrial_Fibrillation.mp3?dest-id=421999",14972554,929,"2018-11-28T16:00:00Z",{"_60":718,"_44":719,"_46":720,"_42":721,"_74":75,"_76":722,"_78":723,"_80":724,"_82":83},"89f596cd-2261-4172-a46d-d2d761765183","Association of Quality of Life Outcomes With Transcatheter Mitral Valve Repair","association-of-quality-of-life-outcomes-with-transcatheter-mitral-valve-repair","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Quality_of_Life_Outcomes_With_Transcatheter_Mitral_Valve_Repair.mp3?dest-id=421999",13283171,824,"2018-11-21T16:00:00Z",{"_60":726,"_44":727,"_46":728,"_42":729,"_74":75,"_76":730,"_78":731,"_80":732,"_82":83},"b3420d86-a3cb-4387-b879-d0806c0fa3fd","Aortic Vascular Inflammation and Coronary Artery Disease in Psoriasis","aortic-vascular-inflammation-and-coronary-artery-disease-in-psoriasis","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Aortic_Vascular_Inflammation_and_Coronary_Artery_Disease_in_Psoriasis.mp3?dest-id=421999",23964728,1486,"2018-09-12T15:00:00Z",{"_60":734,"_44":735,"_46":736,"_42":737,"_74":75,"_76":738,"_78":739,"_80":740,"_82":83},"e6e5f4a9-9f0e-47de-8eab-da172c01212d","Association of Left Ventricular Global Longitudinal Strain With Asymptomatic Severe Aortic Stenosis","association-of-left-ventricular-global-longitudinal-strain-with-asymptomatic-severe-aortic-stenosis","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Left_Ventricular_Global_Longitudinal_Strain_With_Asymptomatic_Severe_Aortic_Stenosis.mp3?dest-id=421999",18475540,1147,"2018-08-15T15:00:00Z",{"_60":742,"_44":743,"_46":744,"_42":745,"_74":75,"_76":746,"_78":747,"_80":748,"_82":83},"ea92acd2-7cbe-4e66-887b-266d767fdf08","Efficacy and Safety of Further Lowering of LDL Cholesterol in Patients Starting With Very Low Levels","efficacy-and-safety-of-further-lowering-of-ldl-cholesterol-in-patients-starting-with-very-low-levels","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Efficacy_and_Safety_of_Further_Lowering_of_LDL_Cholesterol_in_Patients_Starting_With_Very_Low_Levels.mp3?dest-id=421999",22305178,1374,"2018-08-01T15:00:00Z",{"_60":750,"_44":751,"_46":752,"_42":753,"_74":75,"_76":754,"_78":755,"_80":756,"_82":83},"96c34336-cc3e-426d-94cc-2021ed7bab8d","Low-density Lipoprotein Cholesterol by Martin/Hopkins, Friedewald, and Preparative Ultracentrifugation Methods","low-density-lipoprotein-cholesterol-by-martinhopkins-friedewald-and-preparative-ultracentrifugation-methods","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Low-density_Lipoprotein_Cholesterol_by_Martin_Hopkins_Friedewald_and_Preparative_Ultracentrifugation_Methods.mp3?dest-id=421999",17017369,1051,"2018-06-13T15:00:00Z",{"_60":758,"_44":759,"_46":760,"_42":761,"_74":75,"_76":762,"_78":763,"_80":764,"_82":83},"739fb501-3bb7-48ed-b387-917f57f5e1cc","Association of the 2014 and 2017 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults","association-of-the-2014-and-2017-hypertension-guidelines-with-cardiovascular-events-and-deaths-in-us-adults","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_the_2014_and_2017_Hypertension_Guidelines_With_Cardiovascular_Events_and_Deaths_in_US_Adults.mp3?dest-id=421999",18443233,1146,"2018-05-23T15:00:00Z",{"_60":766,"_44":767,"_46":768,"_42":769,"_74":75,"_76":770,"_78":771,"_80":772,"_82":83},"bbe78a61-ff86-43d4-afdd-2157d8d14f71","Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure","evolution-of-left-ventricular-assist-device-therapy-for-advanced-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Evolution_of_Left_Ventricular_Assist_Device_Therapy_for_Advanced_Heart_Failure.mp3?dest-id=421999",12840800,798,"2018-04-18T15:00:00Z",{"_60":774,"_44":775,"_46":776,"_42":777,"_74":75,"_76":778,"_78":779,"_80":780,"_82":83},"16228558-264f-478f-83fc-079676766a23","Passive Detection of Atrial Fibrillation Using a Commercially Available Smartwatch","passive-detection-of-atrial-fibrillation-using-a-commercially-available-smartwatch","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Passive_Detection_of_Atrial_Fibrillation_Using_a_Commercially_Available_Smartwatch.mp3?dest-id=421999",17443695,1087,"2018-03-21T15:00:00Z",{"_60":782,"_44":783,"_46":784,"_42":785,"_74":75,"_76":786,"_78":787,"_80":788,"_82":83},"2284f301-92e2-4d4b-a14d-3c1c397b36c9","Adding Point-of-Care Ultrasound to the Cardiac Physical Exam","adding-point-of-care-ultrasound-to-the-cardiac-physical-exam","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Adding_Point-of-Care_Ultrasound_to_the_Cardiac_Physical_Exam.mp3?dest-id=421999",25216425,1575,"2018-02-28T16:00:00Z",{"_60":790,"_44":791,"_46":792,"_42":793,"_74":75,"_76":794,"_78":795,"_80":796,"_82":83},"ca442a7f-dbeb-4c8c-be40-c86027c9dddf","Elective Coronary Revascularization in Veterans Affairs vs Community Care Hospitals","elective-coronary-revascularization-in-veterans-affairs-vs-community-care-hospitals","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Elective_Coronary_Revascularization_in_Veterans_Affairs_vs_Community_Care_Hospitals.mp3?dest-id=421999",17278986,1078,"2018-01-03T16:00:00Z",{"_60":798,"_44":799,"_46":800,"_42":801,"_74":75,"_76":802,"_78":803,"_80":804,"_82":83},"013d8b27-3ca4-4c9f-a20b-861c7cbe2caa","Medicare Expenditure Growth and Mortality Rates in Patients With AMI","medicare-expenditure-growth-and-mortality-rates-in-patients-with-ami","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Medicare_Expenditure_Growth_and_Mortality_Rates_in_Patients_With_AMI.mp3?dest-id=421999",18792545,1173,"2017-12-20T16:00:00Z",{"_60":806,"_44":807,"_46":808,"_42":809,"_74":75,"_76":810,"_78":811,"_80":812,"_82":83},"0a8debdd-7fd6-4d04-96fc-23bb89993517","Racial Differences and Mortality With N-Terminal Pro–B-Type Natriuretic Peptide","racial-differences-and-mortality-with-n-terminal-prob-type-natriuretic-peptide","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Racial_Differences_and_Mortality_With_N-Terminal_ProB-Type_Natriuretic_Peptide.mp3?dest-id=421999",8347962,1040,"2017-11-22T16:00:00Z",{"_60":814,"_44":815,"_46":816,"_42":817,"_74":75,"_76":818,"_78":819,"_80":820,"_82":83},"7e1776ab-7333-47bd-917e-2837b87c42b1","Outcomes in Women and Minorities After Everolimus-Eluting Stent Implantation","outcomes-in-women-and-minorities-after-everolimus-eluting-stent-implantation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Outcomes_in_Women_and_Minorities_After_Everolimus-Eluting_Stent_Implantation.mp3?dest-id=421999",6097515,759,"2017-10-18T15:00:00Z",{"_60":822,"_44":823,"_46":824,"_42":825,"_74":75,"_76":826,"_78":827,"_80":828,"_82":83},"4c7fdf9d-5128-4de9-b676-6e4c97b07f0a","Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial","hemodynamics-of-transcatheter-and-surgical-aortic-valves-in-the-partner-trial","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Hemodynamics_of_Transcatheter_and_Surgical_Aortic_Valves_in_the_PARTNER_Trial.mp3?dest-id=421999",24572841,1534,"2017-09-27T15:00:00Z",{"_60":830,"_44":831,"_46":832,"_42":833,"_74":75,"_76":834,"_78":835,"_80":836,"_82":83},"b18128f5-9929-453d-973c-a804a1a23fd4","Neighborhood Demographics and Cardiac Arrest Treatment and Outcomes","neighborhood-demographics-and-cardiac-arrest-treatment-and-outcomes","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Neighborhood_Demographics_and_Cardiac_Arrest_Treatment_and_Outcomes.mp3?dest-id=421999",4228620,261,"2017-08-30T15:00:00Z",{"_60":838,"_44":839,"_46":840,"_42":841,"_74":75,"_76":842,"_78":843,"_80":844,"_82":83},"7a7cfc02-2e33-4d2d-af00-97d1282a5ed1","Racial Differences in Survival After In-Hospital Cardiac Arrest","racial-differences-in-survival-after-in-hospital-cardiac-arrest","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Racial_Differences_in_Survival_After_In-Hospital_Cardiac_Arrest.mp3?dest-id=421999",12411521,1546,"2017-08-09T15:00:00Z",{"_60":846,"_44":847,"_46":848,"_42":849,"_74":75,"_76":850,"_78":851,"_80":852,"_82":83},"6f5d6be0-4944-0135-902b-63f4b61a9224","Efficacy and Safety of Spironolactone in Acute Heart Failure","efficacy-and-safety-of-spironolactone-in-acute-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/170712-car-sai-butler.mp3?dest-id=421999",15554718,969,"2017-07-12T15:00:00Z",{"_60":854,"_44":855,"_46":856,"_42":857,"_74":75,"_76":858,"_78":851,"_80":859,"_82":83},"07c2b180-38c2-0135-52fa-452518e2d253","Off-Label Use of Transcatheter Aortic Valve Replacement","off-label-use-of-transcatheter-aortic-valve-replacement","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Off-Label_Use_of_Transcatheter_Aortic_Valve_Replacement.mp3?dest-id=421999",15526968,"2017-06-21T15:00:00Z",{"_60":861,"_44":862,"_46":863,"_42":864,"_74":75,"_76":865,"_78":866,"_80":867,"_82":83},"9eb52f80-22c2-0135-52f8-452518e2d253","Medical Claims Accuracy for Cardiovascular and Bleeding Events After Myocardial Infarction","medical-claims-accuracy-for-cardiovascular-and-bleeding-events-after-myocardial-infarction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Medical_Claims_Accuracy_for_Cardiovascular_and_Bleeding_Events_After_Myocardial_Infarction.mp3?dest-id=421999",8366826,1038,"2017-05-24T15:00:00Z",{"_60":869,"_44":870,"_46":871,"_42":872,"_74":75,"_76":873,"_78":874,"_80":875,"_82":83},"7a5793b0-1c1b-0135-52f8-452518e2d253","Risk-Standardized Readmission Metric and Care Quality in Myocardial Infarction","risk-standardized-readmission-metric-and-care-quality-in-myocardial-infarction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Risk-Standardized_Readmission_Metric_and_Care_Quality_in_Myocardial_Infarction_JAMA_Cardiology.mp3?dest-id=421999",8498369,1052,"2017-04-26T15:00:00Z",{"_60":877,"_44":878,"_46":879,"_42":880,"_74":75,"_76":881,"_78":882,"_80":883,"_82":83},"7462d3a3-6f5b-4efc-a213-00a3480cec7c","Mortality Following Events Occurring Beyond 1 Year After Stenting","mortality-following-events-occurring-beyond-1-year-after-stenting","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Mortality_Following_Events_Occurring_Beyond_1_Year_After_Stenting_JAMA_Cardiology.mp3?dest-id=421999",3328682,411,"2017-03-15T19:27:38Z",{"_60":885,"_44":886,"_46":887,"_42":888,"_74":75,"_76":889,"_78":667,"_80":890,"_82":83},"9801244e-c96a-4277-9fc0-f004e0a5a86c","Early Phenotypes and the Influence of Left Ventricular Wall Thickness","early-phenotypes-and-the-influence-of-left-ventricular-wall-thickness","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Early_Phenotypes_and_the_Influence_of_Left_Ventricular_Wall_Thickness_JAMA_Cardiology.mp3?dest-id=421999",11154951,"2017-02-22T16:00:00Z",{"_60":892,"_44":893,"_46":894,"_42":895,"_74":75,"_76":896,"_78":897,"_80":898,"_82":83},"8a923c2a-61de-4ed7-87b7-cfd52aafb3aa","Cause-Specific Cardiovascular Disease Mortality Among Hispanic Subgroups","cause-specific-cardiovascular-disease-mortality-among-hispanic-subgroups","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Cause-Specific_Cardiovascular_Disease_Mortality_Among_Hispanic_Subgroups_JAMA_Cardiology.mp3?dest-id=421999",4625336,575,"2017-01-18T16:00:00Z",{"_60":900,"_44":901,"_46":902,"_42":903,"_74":75,"_76":904,"_78":905,"_80":898,"_82":83},"008f2fbe-14f5-4b4c-809c-da196ee05603","Challenges in Assessing Cardiovascular Mortality Among US Hispanic/Latino Groups","challenges-in-assessing-cardiovascular-mortality-among-us-hispaniclatino-groups","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Challenges_in_Assessing_Cardiovascular_Mortality_Among_US_Hispanic_Latino_Groups_JAMA_Cardiology.mp3?dest-id=421999",6602515,822,{"_60":907,"_44":908,"_46":909,"_42":910,"_74":75,"_76":911,"_78":912,"_80":913,"_82":83},"9baae8d5-a5ed-470b-8308-fa5b60962477","First Steps Into the Brave New Transdiscipline of Mobile Health","first-steps-into-the-brave-new-transdiscipline-of-mobile-health","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/First_Steps_Into_the_Brave_New_Transdiscipline_of_Mobile_Health.mp3?dest-id=421999",6380089,795,"2016-12-14T16:00:00Z",{"_60":915,"_44":916,"_46":917,"_42":918,"_74":75,"_76":919,"_78":920,"_80":921,"_82":83},"460e6125-5aa5-492e-af8a-ec4104ace950","Pulmonary Arterial Hypertension–Related Hospitalizations","pulmonary-arterial-hypertensionrelated-hospitalizations","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/161116-onc-jai-thenappan.mp3?dest-id=421999",21592324,2694,"2016-11-16T16:00:00Z",{"_60":923,"_44":924,"_46":925,"_42":926,"_74":75,"_76":927,"_78":928,"_80":929,"_82":83},"7fc7cb02-77a1-45d9-ab50-f3a859a96d3a","Intensity of Statin Therapy and Mortality","intensity-of-statin-therapy-and-mortality","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/161109-car-sai-heidenreich.mp3?dest-id=421999",8760942,1091,"2016-11-09T16:00:00Z",{"_60":931,"_44":932,"_46":933,"_42":934,"_74":75,"_76":935,"_78":936,"_80":937,"_82":83},"345d04e1-1bb5-4b1e-a1e9-f828e11c1681","Association of Age at and Time Since Menopause With Cardiovascular Outcomes","association-of-age-at-and-time-since-menopause-with-cardiovascular-outcomes","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Association_of_Age_at_and_Time_Since_Menopause_With_Cardiovascular_Outcomes_JAMA_Cardiology.mp3?dest-id=421999",8034650,999,"2016-09-14T15:00:00Z",{"_60":939,"_44":940,"_46":941,"_42":942,"_74":75,"_76":943,"_78":944,"_80":945,"_82":83},"1e098b0e-80a7-4109-acec-b5c0fbc3d5d1","Antiplatelet Therapy for Long-term Secondary Prevention After AMI","antiplatelet-therapy-for-long-term-secondary-prevention-after-ami","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Antiplatelet_Therapy_for_Long-term_Secondary_Prevention_After_AMI_JAMA_Cardiology.mp3?dest-id=421999",7112448,867,"2016-08-10T15:00:00Z",{"_60":947,"_44":948,"_46":949,"_42":950,"_74":75,"_76":951,"_78":952,"_80":953,"_82":83},"994348d3-e22d-4052-98a7-d98eaabc146b","Management of AMI With Cardiogenic Shock Before and After Exclusion From Reporting","management-of-ami-with-cardiogenic-shock-before-and-after-exclusion-from-reporting","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Management_of_AMI_With_Cardiogenic_Shock_Before_and_After_Exclusion_From_Reporting_JAMA_Cardiology.mp3?dest-id=421999",6241415,778,"2016-07-27T15:00:00Z",{"_60":955,"_44":956,"_46":957,"_42":958,"_74":75,"_76":959,"_78":960,"_80":961,"_82":83},"15b604ee-9140-490e-bbe0-5815ef606a40","Long-term Tolerability of Ticagrelor After Myocardial Infarction","long-term-tolerability-of-ticagrelor-after-myocardial-infarction","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Long-term_Tolerability_of_Ticagrelor_After_Myocardial_Infarction_JAMA_Cardiology.mp3?dest-id=421999",7399657,917,"2016-06-15T15:00:00Z",{"_60":963,"_44":964,"_46":965,"_42":966,"_74":75,"_76":967,"_78":968,"_80":969,"_82":83},"616fbd95-fe42-47de-93fc-29624a541868","Levels of Cardiac Troponin I in Patients With Suspected Acute Coronary Syndrome","levels-of-cardiac-troponin-i-in-patients-with-suspected-acute-coronary-syndrome","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Levels_of_Cardiac_Troponin_I_in_Patients_With_Suspected_Acute_Coronary_Syndrome_JAMA_Cardiology.mp3?dest-id=421999",7530676,920,"2016-06-01T15:01:00Z",{"_60":971,"_44":972,"_46":973,"_42":974,"_74":75,"_76":975,"_78":976,"_80":977,"_82":83},"8a95fb28-fd89-45e1-b12a-54b19cac9c15","Trends and Disparities in Acute Myocardial Infarction by Income Levels","trends-and-disparities-in-acute-myocardial-infarction-by-income-levels","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Trends_and_Disparities_in_Acute_Myocardial_Infarction_by_Income_Levels_JAMA_Cardiology.mp3?dest-id=421999",8244102,1007,"2016-05-11T15:00:00Z",{"_60":979,"_44":980,"_46":981,"_42":982,"_74":75,"_76":983,"_78":984,"_80":985,"_82":83},"4b77e40b-92ac-4966-9ced-407a71e89a25","Telephone CPR Program and Outcomes After Out-of-Hospital Cardiac Arrest","telephone-cpr-program-and-outcomes-after-out-of-hospital-cardiac-arrest","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Telephone_CPR_Program_and_Outcomes_After_Out-of-Hospital_Cardiac_Arrest_JAMA_Cardiology.mp3?dest-id=421999",3639855,226,"2016-05-04T14:59:00Z",{"_60":987,"_44":988,"_46":989,"_42":990,"_74":75,"_76":991,"_78":992,"_80":993,"_82":83},"abc2967c-30f6-43c1-b8c5-48eb1465c157","DPP4 Inhibitors for Diabetes and the Risk for Heart Failure","dpp4-inhibitors-for-diabetes-and-the-risk-for-heart-failure","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/DPP4_Inhibitors_for_Diabetes_and_the_Risk_for_Heart_Failure_JAMA_Cardiology.mp3?dest-id=421999",9384964,1149,"2016-04-13T15:01:00Z",{"_60":995,"_44":996,"_46":997,"_42":998,"_74":75,"_76":999,"_78":819,"_80":1000,"_82":83},"de984c9b-3720-45dd-80c6-4e3a90b6749b","Oral Anticoagulant Therapy in Patients With Atrial Fibrillation","oral-anticoagulant-therapy-in-patients-with-atrial-fibrillation","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/Oral_Anticoagulant_Therapy_in_Patients_With_Atrial_Fibrillation_JAMA_Cardiology.mp3?dest-id=421999",6233520,"2016-03-16T15:00:00Z",{"_60":1002,"_44":1003,"_46":1004,"_42":1005,"_74":75,"_76":1006,"_78":1007,"_80":1008,"_82":83},"db300e22-dde5-438e-b66c-e6ce2df2aab0","JAMA Cardiology Editors' Summary: 2016-2-24 Online First","jama-cardiology-editors-summary-2016-2-24-online-first","https://traffic.libsyn.com/secure/jamacardiologyauthorinterviews/JAMA_Cardiology_Editors_Summary__2016-2-24_Online_First.mp3?dest-id=421999",10586668,1302,"2016-02-24T15:21:25Z","dataUpdateCount",1,"dataUpdatedAt",1771938673370,"error","errorUpdateCount","errorUpdatedAt","fetchFailureCount","fetchFailureReason","fetchMeta","isInvalidated","status","success","fetchStatus","idle","queryKey",[1026,1027,14],"podcasts","detail","queryHash","[\"podcasts\",\"detail\",\"7a567eb0-1c1b-0135-52f8-452518e2d253\"]",{"_24":25,"_26":1031,"_1024":1033,"_1028":1035},{"_28":1032,"_1009":1010,"_1011":25,"_1013":-5,"_1014":6,"_1015":6,"_1016":6,"_1017":-5,"_1018":-5,"_1019":35,"_1020":1021,"_1022":1023},"

Interview with Roxana Mehran, MD, author of Preserving and Promoting Clinical Trial Representativeness: A Review of Existing Strategies and the Path Forward. Hosted by Robert Bonow, MD.

Related Content:

Preserving and Promoting Clinical Trial Representativeness

",[1034,1027,16],"episodeShowNotes","[\"episodeShowNotes\",\"detail\",\"388fa9f4-b276-4a85-8c4c-8910828ef31e\"]","actionData","errors"]

Preserving and Promoting Clinical Trial Representativeness

Episode Description

Never lose your place, on any device